Prominent Perspective on Existing Biological Hallmarks of Alzheimer's Disease

被引：1

作者：

Singh, Namrata ^{[1
,2
]}

Sharma, Srishti ^{[3
]}

Ghosh, Kallol K. ^{[3
]}

Gupta, Bhanushree ^{[4
]}

Kuca, Kamil ^{[2
,5
]}

机构：

[1] DY Patil Univ, Ramrao Adik Inst Technol, Dept Engn Sci, Navi Mumbai 400706, India

[2] Univ Hradec Kralove, Fac Sci, Dept Chem, Rokitanskeho 62, Hradec Kralove 50003, Czech Republic

[3] Pt Ravishankar Shukla Univ, Sch Studies Chem, Raipur 492010, Chhattisgarh, India

[4] Pt Ravishankar Shukla Univ, Ctr Basic Sci, Raipur 492010, Chhattisgarh, India

[5] Univ Hradec Kralove, Res Inst Biomed Sci, Antonina Dvoraka 451-1, Hradec Kralove 50002, Czech Republic

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2024年 / 24卷 / 13期

关键词：

Alzheimer's disease; Biomarkers; beta-amyloid peptide; Tau protein; Neurodegenerative diseases; Diagnosis; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; CSF BIOMARKERS; AMYLOID-BETA; BLOOD BIOMARKERS; TAU; DIAGNOSIS; PATHOLOGY; MARKER;

D O I：

10.2174/0115680266292514240404040341

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Biomarkers are the most significant diagnosis tools tending towards unique approaches and solutions for the prevention and cure of Alzheimer's Disease (AD). The current report provides a clear perception of the concept of various biomarkers and their prominent features through analysis to provide a possible solution for the inhibition of events in AD. Scientists around the world truly believe that crucial hallmarks can serve as critical tools in the early diagnosis, cure, and prevention, as well as the future of medicine. The awareness and understanding of such biomarkers would provide solutions to the puzzled mechanism of this neuronal disorder. Some of the argued biomarkers in the present article are still in an experimental phase as they need to undergo specific clinical trials before they can be considered for treatment.

引用

页码：1120 / 1133

页数：14

共 108 条

[1] Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease [J].

Alexopoulos, Panagiotis ;

Werle, Lukas ;

Roesler, Jennifer ;

Thierjung, Nathalie ;

Gleixner, Lena Sophie ;

Yakushev, Igor ;

Laskaris, Nikolaos ;

Wagenpfeil, Stefan ;

Gourzis, Philippos ;

Kurz, Alexander ;

Perneczky, Robert .

ALZHEIMERS RESEARCH & THERAPY, 2016, 8

[2] Importance of cerebrospinal fluid (CSF) collection protocol for the accurate diagnosis of Alzheimer's disease when using CSF biomarkers [J].

Algeciras-Schimnich, Alicia ;

Bornhorst, Joshua A. .

ALZHEIMERS & DEMENTIA, 2024, 20 (05) :3657-3658

[3] Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers [J].

Alvarez-Sanchez, Lourdes ;

Pena-Bautista, Carmen ;

Ferre-Gonzalez, Laura ;

Cubas, Laura ;

Balaguer, Angel ;

Casanova-Estruch, Bonaventura ;

Baquero, Miguel ;

Chafer-Pericas, Consuelo .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)

[4] Early onset diagnosis in Alzheimer's disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid [J].

An, Jusung ;

Kim, Kyeonghwan ;

Lim, Ho Jae ;

Kim, Hye Yun ;

Shin, Jinwoo ;

Park, Inwook ;

Cho, Illhwan ;

Kim, Hyeong Yun ;

Kim, Sunghoon ;

Mclean, Catriona ;

Choi, Kyu Yeong ;

Kim, Youngsoo ;

Lee, Kun Ho ;

Kim, Jong Seung .

NATURE COMMUNICATIONS, 2024, 15 (01)

[5] Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics [J].

Arslan, Burak ;

Zetterberg, Henrik ;

Ashton, Nicholas J. .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (06) :1063-1069

[6] Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology [J].

Ashton, Nicholas J. ;

Brum, Wagner S. ;

Di Molfetta, Guglielmo ;

Benedet, Andrea L. ;

Arslan, Burak ;

Jonaitis, Erin ;

Langhough, Rebecca E. ;

Cody, Karly ;

Wilson, Rachael ;

Carlsson, Cynthia M. ;

Vanmechelen, Eugeen ;

Montoliu-Gaya, Laia ;

Lantero-Rodriguez, Juan ;

Rahmouni, Nesrine ;

Tissot, Cecile ;

Stevenson, Jenna ;

Servaes, Stijn ;

Therriault, Joseph ;

Pascoal, Tharick ;

Lleo, Alberto ;

Alcolea, Daniel ;

Fortea, Juan ;

Rosa-Neto, Pedro ;

Johnson, Sterling ;

Jeromin, Andreas ;

Blennow, Kaj ;

Zetterberg, Henrik .

JAMA NEUROLOGY, 2024, 81 (03) :255-263

[7] Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology [J].

Ashton, Nicholas J. ;

Pascoal, Tharick A. ;

Karikari, Thomas K. ;

Benedet, Andrea L. ;

Lantero-Rodriguez, Juan ;

Brinkmalm, Gunnar ;

Snellman, Anniina ;

Scholl, Michael ;

Troakes, Claire ;

Hye, Abdul ;

Gauthier, Serge ;

Vanmechelen, Eugeen ;

Zetterberg, Henrik ;

Rosa-Neto, Pedro ;

Blennow, Kaj .

ACTA NEUROPATHOLOGICA, 2021, 141 (05) :709-724

[8] Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment [J].

Assini, A ;

Cammarata, S ;

Vitali, A ;

Colucci, M ;

Giliberto, L ;

Borghi, R ;

Inglese, ML ;

Volpe, S ;

Ratto, S ;

Dagna-Bricarelli, F ;

Baldo, C ;

Argusti, A ;

Odetti, P ;

Piccini, A ;

Tabaton, M .

NEUROLOGY, 2004, 63 (05) :828-831

[9] Biomarkers for Alzheimer's Disease Early Diagnosis [J].

Auso, Eva ;

Gomez-Vicente, Violeta ;

Esquiva, Gema .

JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03) :1-27

[10] Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease [J].

Bateman, Randall J. ;

Xiong, Chengjie ;

Benzinger, Tammie L. S. ;

Fagan, Anne M. ;

Goate, Alison ;

Fox, Nick C. ;

Marcus, Daniel S. ;

Cairns, Nigel J. ;

Xie, Xianyun ;

Blazey, Tyler M. ;

Holtzman, David M. ;

Santacruz, Anna ;

Buckles, Virginia ;

Oliver, Angela ;

Moulder, Krista ;

Aisen, Paul S. ;

Ghetti, Bernardino ;

Klunk, William E. ;

McDade, Eric ;

Martins, Ralph N. ;

Masters, Colin L. ;

Mayeux, Richard ;

Ringman, John M. ;

Rossor, Martin N. ;

Schofield, Peter R. ;

Sperling, Reisa A. ;

Salloway, Stephen ;

Morris, John C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :795-804

← 1 2 3 4 5 6 7 8 9 10 →